Print Friendly
E-mail Page
Share PagePress Releases
April 30, 2009
Salk Receives $6.6 Million Grant to Develop Stem Cell-Based Treatments for Incurable Diseases
La Jolla, CA -- The Salk Institute for Biological Studies has been awarded a $6.6 million grant – the largest single award in the latest competition -- by the California Institute Regenerative Medicine (CIRM) for research aimed at translating basic science into clinical cures. The funds are part of $67.7 million Early Translational Grants CIRM provided to 15 research organizations on Wednesday.
read more >>
April 28, 2009
Salk scientist Marc Montminy elected to National Academy of Sciences
La Jolla, CA – Salk researcher Marc R. Montminy, M.D., Ph.D., a professor in the Clayton Foundation Laboratories for Peptide Biology, has been elected a member of the National Academy of Sciences, the nation's most prestigious honorary society for scientists. The Academy made the announcement today during its 146th annual meeting in Washington, DC.
read more >>
April 22, 2009
Salk Launches Center for Nutritional Genomics with $5.5 Million Grant from Helmsley Trust
La Jolla, CA -- The Salk Institute has received a $5.5 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to launch the Salk Center for Nutritional Genomics. The new Center will employ a molecular approach to nutrition and its impact on the role of metabolism on the immune system, cancer, diabetes and lifespan, thereby increasing the understanding of how nutrients affect health.
read more >>
April 21, 2009
Repairing a 'bad' reputation?
La Jolla, CA—New research at the Salk Institute for Biological Studies casts the role of a neuronal growth factor receptor—long suspected to facilitate the toxic effects of beta amyloid in Alzheimer's disease—in a new light, suggesting the molecule actually protects the neuron in the periphery from beta amyloid-induced damage.
read more >>
April 07, 2009
How the retina works: Like a multi-layered jigsaw puzzle of receptive fields
La Jolla, CA—About 1.25 million neurons in the retina -- each of which views the world only through a small jagged window called a receptive field -- collectively form the seamless picture we rely on to navigate our environment. Receptive fields fit together like pieces of a puzzle, preventing "blind spots" and excessive overlap that could blur our perception of the world, according to researchers at the Salk Institute for Biological Studies.
read more >>
March 26, 2009
Salk scientist -- one of 50 nationwide -- selected as HHMI Early Career Scientist
La Jolla, CA—Salk Institute scientist Reuben J. Shaw, Ph.D., has been selected a Howard Hughes Medical Institute Early Career Scientist, the HHMI announced today.
read more >>
March 26, 2009
Salk Institute Signs Strategic Alliance with sanofi-aventis
La Jolla, CA—The Salk Institute today announced that it has signed a strategic alliance agreement with sanofi-aventis, establishing a joint program that supports cutting-edge research and promotes an exchange of discoveries focused on scientific advances and therapeutic applications.
read more >>
March 25, 2009
Visual attention: how the brain makes the most of the visible world
La Jolla, CA—The visual system has limited capacity and cannot process everything that falls onto the retina. Instead, the brain relies on attention to bring salient details into focus and filter out background clutter. Two recent studies by researchers at the Salk Institute for Biological Studies, one study employing computational modeling techniques and the other experimental techniques, have helped to unravel the mechanisms underlying attention.
read more >>
March 24, 2009
Forget it! A biochemical pathway for blocking your worst fears?
La Jolla, CA — A receptor for glutamate, the most prominent neurotransmitter in the brain, plays a key role in the process of "unlearning," report researchers at the Salk Institute for Biological Studies. Their findings, published in the current issue of the Journal of Neuroscience, could eventually help scientists develop new drug therapies to treat a variety of disorders, including phobias and anxiety disorders, particularly post-traumatic stress disorder.
read more >>
March 13, 2009
Stem Cells Yield New Clues to Glut of Glial Cells in Down's Syndrome, Glioblastoma, and Alzheimer's Disease
La Jolla, CA—A newly identified molecular pathway that directs stem cells to produce glial cells yields insights into the neurobiology of Down's syndrome and a number of central nervous system disorders characterized by too many glial cells, according to a recent study by researchers at the Salk Institute for Biological Studies.
read more >>